Evidence-led education
PLUSGBUK / MEDICINES / DIAZEPAM 20 Sep 2026

Medicines · Evidence guide

Diazepam: Uses, Side Effects, Dependence and Safe Use

Written by Daniel Mercer
Updated 20 September 2026
Reading time 4 min
Clinical review Jennifer Jan, MD
Diazepam: Uses, Side Effects, Dependence and Safe Use

Diazepam is an established medicine, not a routine long-term answer to anxiety. That distinction matters because benzodiazepines can be very effective over a short period while also producing tolerance, dependence and difficult withdrawal when use continues.

The NHS uses diazepam for several different reasons, including severe anxiety, muscle spasms, seizures and sedation before some procedures. The risks depend partly on why it is being used, how long treatment continues and what other medicines or substances are taken alongside it.

What diazepam is

Diazepam belongs to the benzodiazepine group of medicines. It enhances the effect of GABA, an inhibitory signalling system in the brain. The result can be reduced anxiety, muscle relaxation, sedation and anticonvulsant activity.

These effects explain both its usefulness and many of its adverse effects. A medicine that reduces nervous-system activity can also reduce alertness, coordination and reaction speed.

Why diazepam is prescribed

Diazepam has several legitimate clinical uses, and they should not be treated as interchangeable.

  • It may be used for severe anxiety for a limited period.
  • It can help relieve some muscle spasms.
  • It has a role in managing certain seizures.
  • It may be used for sedation around medical procedures.

For generalised anxiety disorder, NICE advises against routine benzodiazepine treatment except as a short-term measure during crises. That is because the immediate calming effect has to be weighed against tolerance and dependence.

Drowsiness is not the only impairment

Diazepam can cause sleepiness, reduced alertness, slower reactions, poor coordination and memory problems. Some people describe these effects as feeling “calm”, but clinically they are still impairment.

This matters for driving, operating machinery and any task where reaction time or balance is important.

Older or frail adults can be particularly sensitive to sedative effects and falls.

Alcohol and other sedatives increase risk

Combining diazepam with alcohol can substantially increase central nervous system depression. The same concern applies to other sedating medicines and drugs.

The problem is not merely “extra sleepiness”. Combined depressant effects can impair consciousness, coordination and, in some combinations, breathing.

Our guide to diazepam and alcohol explains why the interaction deserves more caution than a routine side-effect warning.

Dependence can develop at prescribed doses

Dependence does not automatically mean misuse or addiction. A person can take diazepam exactly as prescribed and still develop physical dependence if treatment continues long enough.

The MHRA states that benzodiazepine dependence can become established within weeks. In January 2026 it strengthened packaging and patient-information warnings for benzodiazepines and related medicines so that the risks of addiction, dependence, tolerance and withdrawal are stated more clearly.

That distinction is important. Physical dependence means the nervous system has adapted to the drug and withdrawal symptoms may appear if it is reduced too quickly. Addiction involves a broader pattern of impaired control and continued use despite harm.

See our guide to diazepam dependence.

Why diazepam should not simply be stopped after long-term use

Suddenly stopping a benzodiazepine after dependence has developed can produce rebound anxiety, insomnia, tremor, sweating, perceptual disturbances and, in severe cases, seizures or psychosis.

The NHS advises gradual dose reduction rather than abrupt stopping. The appropriate taper is individual and depends on treatment duration, dose, symptoms and other clinical factors.

This is not an area where a generic internet schedule should replace medical supervision.

Our diazepam withdrawal guide explains the difference between recurrence of the original condition, rebound symptoms and withdrawal.

How long is diazepam usually used?

For anxiety and insomnia, benzodiazepine treatment is generally intended to be short. NHS and MHRA guidance commonly refers to a maximum of around four weeks for these indications.

That does not mean every prescription lasting longer than four weeks is automatically inappropriate. Diazepam also has other clinical uses, and individual circumstances differ. It does mean that continuing treatment deserves active review rather than automatic renewal.

Diazepam is a controlled drug

Diazepam is a prescription-only benzodiazepine and a Class C controlled drug in the UK.

Controlled-drug status affects possession and supply outside legitimate medical use. GOV.UK lists benzodiazepines, including diazepam, under Class C.

Unauthorised possession of a Class C drug can carry a maximum penalty of two years in prison, an unlimited fine, or both. Supply and production can carry up to 14 years, an unlimited fine, or both.

For the legal framework, see diazepam and UK controlled-drug law.

Online diazepam carries an additional problem: identity

A tablet stamped with a familiar strength or brand marking is not proof that it came through a regulated pharmaceutical supply chain.

Unauthorised online medicines may contain a different dose, another benzodiazepine or an entirely different substance. Packaging can also be copied.

If the question is how to obtain diazepam legitimately, the relevant route is through an appropriate prescriber and regulated pharmacy, not visual inspection of tablets.

See our guide to buying diazepam online in the UK safely and legally.

When to seek help

Call 999 if someone taking diazepam becomes unconscious, cannot be woken normally or has serious breathing difficulty, particularly where alcohol, opioids or other sedatives may also have been taken.

For dependence or withdrawal concerns, speak with the prescriber, pharmacist or another healthcare professional rather than stopping suddenly.

References

Written by

Daniel Mercer

Daniel Mercer is a health and drug policy writer covering ketamine, harm reduction, controlled substances and emerging mental health treatments. He translates clinical research, UK public-health guidance and drug policy into clear information for non-specialist readers, with particular attention to the differences between medically supervised treatment and substances obtained through unregulated channels.

Jennifer Jan MD
Clinically reviewed by

Jennifer Jan, MD